Sogeval products are going to give us a foot in more clinics than we could have ever imagined. Some of those clinics will be excited to hear about our "new" heartworm preventative. Some will buy in on the bundling program we create, unless our crack marketing department screws that up as well.
Point - Counter Point
Point 1: We have the best topical Flea and Tick product. It covers more bugs than anything else.
Counter Point: The movement toward orals is palpable. We tried to slow it down with WWFTB. Despite our vast efforts WWFTB has not turned any heads. What is our genius solution? WWFTB 2.0. Naming it "2.0" would indicate that it had been improved, or radically changed from the original "1.0" version.
Point 2: Ceva wants us to promote the profitability and protection of combining Vectra and PH6.
Counter Point: Well, don't promote it with any marketing materials because that will make our Distributor partners mad since they don't get paid on PH6.
Point 3: Doctor, I hear that your customers are asking for Nexgard, but you can get it on 800 Pet Meds and Merial promised you that Pinkerton would protect you. We are vet still exclusive!
Counter Point: Vet exclusive only matters if the Vet values it, and it is obvious that they don't. I think they are shooting themselves in the foot, but Ceva is shooting themselves in the foot by not pursing what the market is telling you it wants; an oral product that works (no throwing up in dogs, no abnormalities in puppies).
Am I wrong in any of these points or counter points?
